AMT-151 in Patients With Selected Advanced Solid Tumours
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced Solid Tumor|Advanced Cancer|Advanced Carcinoma|Ovarian Cancer|Ovarian Carcinoma|Ovarian Epithelial Cancer|Ovarian Endometrioid Adenocarcinoma|Endometrial Cancer|Endometrial Adenocarcinoma|Endometrial Serous Adenocarcinoma|Endometrial Endometrioid Adenocarcinoma|Endometrial Clear Cell Adenocarcinoma|Lung Adenocarcinoma|Triple Negative Breast Cancer|Pancreatic Ductal Adenocarcinoma|Malignant Pleural Mesothelioma|Ovarian Clear Cell Carcinoma|Ovarian Clear Cell Adenocarcinoma|Ovarian Mucinous Adenocarcinoma
Interventions: DRUG: AMT-151
Sponsor: Multitude Therapeutics Inc.
Collaborators: Tigermed Consulting Co., Ltd